Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity. Apr 2011 - Int. J. Oncol.; 38(6):1791-2423 [PMID:21424118] [Fournier P] [Aigner M] [Schirrmacher V]
Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25. Nov 2010 - Int. J. Oncol.; 37(6):1791-2423 [PMID:21042712] [Fournier P] [Aigner M] [Schirrmacher V]
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine. Sep 2010 - Int. J. Oncol.; 37(5):1791-2423 [PMID:20878068] [Fournier P] [Aigner M] [Schirrmacher V]
An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins. Mar 2008 - Int. J. Oncol.; 32(4):1019-6439 [PMID:18360705] [Aigner M] [Janke M] [Lulei M] [Beckhove P] [Fournier P] [Schirrmacher V]
